MRC Agrotech has clarified the use of funds from its upcoming preferential share issue. The company will raise approximately 4.29 Cr by allotting 2,197,910 equity shares at ₹19.50 each. These proceeds are now earmarked for 3.13 Cr towards incremental working capital, 1.00 Cr for future funding (including R&D and product launches), and 0.15 Cr for general corporate purposes, deviating from initial plans to repay borrowings. Additionally, the company is set to acquire MARSAPI Lifesciences Private Limited by issuing 8,642,097 equity shares valued at roughly 16.85 Cr. To support these initiatives, MRC Agrotech's authorized share capital will increase from 20.50 Cr to 35.50 Cr.